Transitions launches Vantage lens and dedicated educational resource site

Article

Transitions Optical has launched its Transitions Vantage lenses, which darken and polarize on exposure to ultraviolet light, according to a recent announcement from the company.

Pinellas Park, FL - Transitions Optical has launched its Transitions Vantage lenses, which darken and polarize on exposure to ultraviolet light, according to a recent announcement from the company.

Transitions also established a Web site [www.transitionsvantage.com] designed to help professionals better understand the product and how to recommend it to patients.

“Education has always been a critical component to successfully introducing a new product in our industry,” said Alexis Cardona, chief marketing officer, Transitions Optical.  “This time, we've not only expanded our family of products with Transitions Vantage lenses but we've also introduced a completely new technology, variable polarization, to the industry making proper education even more critical. By offering a central resource for information, we hope to make it easy for our partners to understand this new technology and how it can offer patients a completely new benefit.”

Eye-care professionals who visit the site can access product information, instructional videos, educational tools and marketing materials. Upon completion of a short quiz, doctors can sign up to receive a complimentary launch kit, which includes a Transitions Vantage lens lorgnette sample, a glare simulator, consumer brochures, a recommendation guide, frequently asked questions, and a final inspection guide with film. 

Transitions Vantage lenses will officially become available to consumers on May 1 in a variety of materials and exclusively in gray.

For more articles in this issue of InDispensable, click here.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Erin Tomiyama, OD, PhD, FAAO, offers actionable advice for myopia management and perspective for practitioners ready to refine their approach.
Extended lotilaner 0.25% therapy shows meibomian gland benefits
Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.
Carolyn Majcher, OD, FAAO, details a Collaborative Care Symposium 2025 presentation given with Prethy Rao, MD.
Mitch Ibach, OD, FAAO, details the importance of identifying the best candidates and practicing comanagement for refractive surgery.
Lori Wright, JD, sat down to talk about a presentation at Collaborative Care Symposium about the risk under federal statutes and how to minimize that risk as an optometrist or an ophthalmic practice.
Rachelle Lin, OD, MS, FAAO, on collaborating more effectively on neovascular retinal cases
Mark Bullimore, MCOptom, PhD, details the importance of preparing optometric students for myopic patient care in a Collaborative Care Symposium (CCS) 2025 presentation.
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
Mitch Ibach, OD, FAAO, details the importance to unveiling the underlying cause of dry eye in a CCS 2025 presentation.
© 2025 MJH Life Sciences

All rights reserved.